| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Foghorn Therapeutics Inc. | Chief Scientific Officer | Stock Option (right to buy) | 300,000 | $1,713,000 | $5.71 | 30 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc. | 30 Jan 2026 | 1 | +$1,713,000 | 4 | Chief Scientific Officer | 02 Feb 2026, 16:01 |
| FHTX | Foghorn Therapeutics Inc. | 22 Jan 2025 | 1 | +$611,800 | 4 | Chief Scientific Officer | 24 Jan 2025, 16:09 |
| FHTX | Foghorn Therapeutics Inc. | 09 Sep 2024 | 1 | -$190,000 | 4 | Chief Scientific Officer | 11 Sep 2024, 16:00 |
| FHTX | Foghorn Therapeutics Inc. | 24 Jan 2024 | 1 | +$336,600 | 4 | Chief Scientific Officer | 25 Jan 2024, 16:02 |
| FHTX | Foghorn Therapeutics Inc. | 26 Jan 2023 | 1 | $0 | 4 | Chief Scientific Officer | 30 Jan 2023, 16:03 |
| FHTX | Foghorn Therapeutics Inc. | 11 Aug 2022 | 2 | +$6,912 | 4 | Chief Scientific Officer | 15 Aug 2022, 18:15 |
| FHTX | Foghorn Therapeutics Inc. | 25 May 2022 | 4 | +$14,320 | 4 | Chief Scientific Officer | 27 May 2022, 16:10 |
| FHTX | Foghorn Therapeutics Inc. | 26 Jan 2022 | 1 | $0 | 4 | Chief Scientific Officer | 28 Jan 2022, 15:27 |
| FHTX | Foghorn Therapeutics Inc. | 10 Jan 2022 | 0 | $0 | 3 | Chief Scientific Officer | 11 Jan 2022, 15:03 |